Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.46 BRL | -11.61% | -4.17% | +150.17% |
Apr. 18 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
Apr. 17 | Biocon Limited Signs an Exclusive Licensing and Supply Agreement with Biomm S.A | CI |
Sales 2022 | 105M 20.33M | Sales 2023 | 118M 22.89M | Capitalization | 470M 91.01M |
---|---|---|---|---|---|
Net income 2022 | -92M -17.82M | Net income 2023 | -81M -15.69M | EV / Sales 2022 | 5.9 x |
Net Debt 2022 | 67.72M 13.12M | Net Debt 2023 | 125M 24.19M | EV / Sales 2023 | 5.03 x |
P/E ratio 2022 |
-5.37
x | P/E ratio 2023 |
-5.93
x | Employees | 130 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 47.6% |
1 day | -11.61% | ||
1 week | -4.17% | ||
Current month | -28.38% | ||
1 month | -9.68% | ||
3 months | +46.06% | ||
6 months | +149.31% | ||
Current year | +150.17% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Director of Finance/CFO | - | 19-04-15 | |
Luciano Vilela
CTO | Chief Tech/Sci/R&D Officer | - | 14-02-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 14-01-31 | |
Director/Board Member | 84 | 15-10-12 | |
Director/Board Member | 81 | 13-12-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 14.46 | +4.10% | 204,600 |
24-05-27 | 13.89 | +5.95% | 69,600 |
24-05-24 | 13.11 | -2.96% | 52,800 |
24-05-23 | 13.51 | -6.51% | 50,600 |
24-05-22 | 14.45 | -4.24% | 142,900 |
Delayed Quote Sao Paulo, May 28, 2024 at 04:07 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+150.17% | 239M | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |
- Stock Market
- Equities
- BIOM3 Stock